This company was established in 2011 as PT.MAB Supply and transformed as PT.Sentrum Diagnostik Indonesia (PT. SEDIA) by 2024. The new management of PT. SEDIA is managed by an individual who possesses exceptional talent and over 30 years of experience in the IVD field. Additionally, the company hired a comprehensive marketing and scientific team with extensive knowledge and expertise in the IVD field. Our primary focus is on the in-vitro diagnostics industry, where we strive to deliver trustworthy, innovative, and the best quality products and services.
To become the leading Indonesian In-Vitro Diagnostic Company with a focus on sustainable growth.
We offer affordable and unique In-Vitro Diagnostic products and services to assist the government in enhancing health outcomes for a more beneficial quality of life.
The word "Sedia" in Bahasa means "readiness". It emphasizes our dedication to serving and establishing confidence with our consumers. Each and every product and service we offer has an enormous impact on patients, society, and the environment. We firmly believe that by providing our clients with trustworthy, unique, and innovative products and services, we will continue to grow across our customers as one big family in the field of healthcare services.
